Posted at 25th February 2013 by Ryan Luce
written by Michael O’Leary
Two companies announced clinical trials in the last three weeks aimed at bringing insulin taken by mouth to market.
Generex Biotechnology Corporation announced at the end of January results of a phase III clinical trial showing that its oral insulin spray Oral-lyn™ is as effective as subcutaneously injected regular insulin. The 12-week study conducted by an Indian licensee of Generex involved 209 men and women with type 2 diabetes at 14 clinics in India who did not have well controlled blood sugar levels with oral diabetic drugs.